These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 26121640)
1. Salivary MicroRNA in Pancreatic Cancer Patients. Humeau M; Vignolle-Vidoni A; Sicard F; Martins F; Bournet B; Buscail L; Torrisani J; Cordelier P PLoS One; 2015; 10(6):e0130996. PubMed ID: 26121640 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556 [TBL] [Abstract][Full Text] [Related]
3. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087 [TBL] [Abstract][Full Text] [Related]
4. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284 [TBL] [Abstract][Full Text] [Related]
6. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Torrisani J; Bournet B; du Rieu MC; Bouisson M; Souque A; Escourrou J; Buscail L; Cordelier P Hum Gene Ther; 2009 Aug; 20(8):831-44. PubMed ID: 19323605 [TBL] [Abstract][Full Text] [Related]
7. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230 [TBL] [Abstract][Full Text] [Related]
10. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
11. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862 [TBL] [Abstract][Full Text] [Related]
14. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699 [TBL] [Abstract][Full Text] [Related]
15. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Duz MB; Karatas OF; Guzel E; Turgut NF; Yilmaz M; Creighton CJ; Ozen M Cell Oncol (Dordr); 2016 Apr; 39(2):187-93. PubMed ID: 26650483 [TBL] [Abstract][Full Text] [Related]
16. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells. Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318 [TBL] [Abstract][Full Text] [Related]
18. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. Xie Z; Chen G; Zhang X; Li D; Huang J; Yang C; Zhang P; Qin Y; Duan Y; Gong B; Li Z PLoS One; 2013; 8(4):e57502. PubMed ID: 23560033 [TBL] [Abstract][Full Text] [Related]
19. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data. Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534 [TBL] [Abstract][Full Text] [Related]